Jia, et al. treated 103 cases of mammary diseases (78 cases of mammary gland lobule proliferation, 11 cases of fibroma, 11 cases of mastadenitis, and 3 cases of breast cancer) with an external medication. The application was made from Ru Xiang, Chan Su, Ban Xia, Xue Ke, Bing Pian, and Da Huang. The herbs were ground into powder and made into a paste using sesame oil as the medium. One unit of treatment called for applying the paste five times over a 15-day period. The results: 88 cases significantly improved, 11 cases improved, 4 cases did not respond to the treatment, with a total effective rate of 97.8%.( 7)
Based on TCM's principle of treating advanced (stage IV) breast cancer by activating the blood to resolve stasis, softening hard lumps and dispelling nodes, and clearing away heart and toxic substances, Zhou, et al. used an anti-cancer pain-relieving formula both internally and externally to treat advanced chemotherapy-resistant breast cancer that had failed to respond to endocrine treatments, and reported a total effective rate of 67%. The internal-external duo approach to treating advanced breast cancer has these advantages: 1) it is an over-all treatment and a local treatment at the same time; 2) it not only shrinks the tumor, it also kills pain and fights infection; and 3) it treats cancer without impairing the body's otherwise normal functions. Generally speaking, by promoting blood circulation and resolving blood stasis, blood viscosity can be reduced and hypercoagulability improved, making it possible for cancer-fighting medication to overcome the barriers of cancerous tissues and exerts its pharmacological actions.( 8)
In treating 10 cases of mamary tumor, Wang used a formula consisting of the following herbs: Pu Gong Ying (Dandelion), Chai Hu (Bupleurum), Bai Shao (White Peony Root), Dang Gui (Dang Gui), Fu Ling (Hoelen), Bai Zhu (Atractylodes), Bai Hua She She Cao (Oldenlandia), Ban Zhi Lian (Barbat Skullcap), Ji Xue Teng (Milettia), Hong Hua (Carthamus), Gan Cao (Licorice), processed Zhi Zi (Gardenia), and Yin Yang Huo (Epimedium). Modifications were made to render the treatment better suited for individual patients' conditions, and one unit of treatment lasted 30 days (one dose daily). The results: 6 cases significantly improved, 2 cases improved, and the remaining 2 cases did not respond to the treatment, with a total effective rate of 80%.( 9)
Wei, et al. treated 68 cases of post-mammary cancer surgery limb swelling with a formula consisting of the following herbs: Dang Shen (Salvia), Qin Jiao (Gentian Root), Jin Yin Hua (Lonicera Flower), Huang Qi (Astragalus Root), Da Qing Ye (Isatis Leaf), Dan Shen (Salvia), Yan Hu Suo (Corydalis Tuber), Fu Ling (Hoelen), Tao Ren (Persica), and Fang Ji (Stephania). One daily dose of the formula was divided into two parts for morning and evening administrations, and one unit of treatment consisted of 7 consecutive days. The results: 42 cases significantly improved, 24 cases improved, 2 cases did not respond to the treatment, with a total effective rate of 97.05%.( 10)
Using herbs known for their actions of invigorating qi and blood, nourishing yin, dissolving stasis, and removing toxicity, Zhuo devised a formula to treatment for 36 breast cancer patients who have undergone surgery, radiation, or chemotherapy. The results: 22 patients significantly improved, 12 patients improved, and 2 patients did not respond to the treatment, with a total effective rate of 94.4%.( 11)
In recent years, traditional Chinese medicine has made long strides in advancing breast cancer research. Looking ahead, the next challenge facing TCM is to incorporate modern medical technologies and means into its practice, which has always rightly advocated shoring up the body's own defense by nourishing vital qi, strengthening resistance, and keeping pathogenic factors at bay, so that its advantages in treating breast cancer will have a chance to truly shine.
|